SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : BioLase Technology, Inc. (BLTI)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: lizard lick who wrote (542)8/5/1999 4:34:00 PM
From: J Stone  Read Replies (1) of 706
 
"BLTI recently signed a one year worldwide distribution license for its LazerSmile Tooth Whitening System with Tactica International for an annual minimum quota of 500,000 units. Tactica will pay a royalty per unit to BLTI and has taken over the marketing of LazerSmile, which began in July. We estimate the license can generate $2-$3 million in sales over the next 12 months, of which 90% should be profit. "

A few comments...

The license is only for 1 year?

At a minimum annual quota of 500K units, if BLTI only sees $2m - 3m, then that's only $4-$6 per unit. This strikes me as kind of low. Seems to me a better deal could have been negotiated. Also, wasn't there supposed to be an advance on the first year's minimum?

Separately...

Does anyone know when the next earnings announcement will be?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext